Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Response01:28

Inflammatory Response

7.2K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
7.2K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

35
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
35
Inflammation01:38

Inflammation

55.1K
Overview
55.1K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

82
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
82
T Cell Types and Functions01:24

T Cell Types and Functions

1.4K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

50
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
50

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Histological validation of artificial intelligence-driven automatic plaque characterization in coronary OCT: a head-to-head comparison with clinicians.

Cardiology plus·2026
Same author

The N-terminus of apolipoprotein B mediates the interaction of atherogenic lipoproteins with endothelial cells.

The Journal of clinical investigation·2026
Same author

Associations of 10-year predicted ASCVD risk by the PREVENT equations with AI-analyzed coronary atherosclerotic plaque characteristics.

American journal of preventive cardiology·2026
Same author

Sex-based multiomics analysis uncovers metabolic and molecular mediators linking MASH and atherosclerosis.

JHEP reports : innovation in hepatology·2026
Same author

Changes in absolute coronary blood flow and myocardial resistance after percutaneous coronary intervention.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2026
Same author

HDL Regulates TGFβ-Receptor Lipid Raft Partitioning, Restoring Contractile Features of Cholesterol-Loaded Vascular Smooth Muscle Cells.

JACC. Basic to translational science·2026

Related Experiment Video

Updated: Sep 12, 2025

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
09:06

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice

Published on: February 20, 2019

8.4K

Inflammation reprogramming and immunomodulation: Next-generation treatments for atherosclerosis.

Robin P Choudhury1, Rupen Hargreaves2, Jason Chai1

  • 1Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.

Cell Reports. Medicine
|August 9, 2025
PubMed
Summary

Current atherosclerosis treatments manage risk factors but overlook established disease. Next-generation therapies offer personalized, mechanistic approaches to potentially reverse atherosclerosis progression.

Keywords:
atherosclerosisatherosclerosis regressionclonal hematopoiesisdiabetesepigeneticinflammationtherapeuticstrained immunity

More Related Videos

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

13.3K
Flow Cytometry Analysis of Immune Cells Within Murine Aortas
15:15

Flow Cytometry Analysis of Immune Cells Within Murine Aortas

Published on: July 1, 2011

34.8K

Related Experiment Videos

Last Updated: Sep 12, 2025

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
09:06

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice

Published on: February 20, 2019

8.4K
A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

13.3K
Flow Cytometry Analysis of Immune Cells Within Murine Aortas
15:15

Flow Cytometry Analysis of Immune Cells Within Murine Aortas

Published on: July 1, 2011

34.8K

Area of Science:

  • Cardiovascular Medicine
  • Translational Medicine
  • Molecular Biology

Background:

  • Current atherosclerosis treatments focus on population-derived risk factors like LDL-cholesterol, blood pressure, and smoking.
  • These strategies primarily address disease development and complications, often neglecting patients with established atherosclerosis.
  • Epidemiological studies have guided current risk factor management approaches.

Purpose of the Study:

  • To transition from population-based risk factor management to patient-specific, mechanistic treatments for atherosclerosis.
  • To explore next-generation therapeutic strategies capable of reversing or regressing established atherosclerotic disease.
  • To incorporate systems-level interventions beyond the atherosclerotic plaque itself.

Main Methods:

  • Leveraging contemporary biological knowledge and advanced technologies.
  • Developing targeted therapies including monoclonal antibodies, small interfering RNA (siRNA), and mRNA.
  • Exploring novel approaches such as epigenetic reprogramming and gene editing.
  • Characterizing patient-level disease processes mechanistically.

Main Results:

  • Emerging biological knowledge enables a shift towards personalized atherosclerosis treatments.
  • Next-generation therapies show potential for disease reversal or regression.
  • Systems-level interventions offer a broader therapeutic scope.

Conclusions:

  • A paradigm shift is occurring in atherosclerosis treatment, moving towards precision medicine.
  • Advanced biological insights and technologies are paving the way for novel therapeutic modalities.
  • Future treatments will likely be tailored to individual patient disease processes, aiming for regression.